Cancer-related Venous Thromboembolic Disease - Cohort Study

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2034

Study Completion Date

November 30, 2034

Conditions

Thrombosis EmbolismThromboses, VenousCancer

Interventions

OTHER

Collection of biological samples

Collecte of blood and urine samples

All Listed Sponsors

lead

University Hospital, Brest

OTHER

NCT06393764 - Cancer-related Venous Thromboembolic Disease - Cohort Study | Biotech Hunter | Biotech Hunter